Mankind Pharma Geçmiş Kazanç Performansı
Geçmiş kriter kontrolleri 6/6
Mankind Pharma has been growing earnings at an average annual rate of 12.6%, while the Pharmaceuticals industry saw earnings growing at 13.4% annually. Revenues have been growing at an average rate of 16.4% per year. Mankind Pharma's return on equity is 20.8%, and it has net margins of 18.4%.
Anahtar bilgiler
12.6%
Kazanç büyüme oranı
12.6%
EPS büyüme oranı
| Pharmaceuticals Sektör Büyümesi | 17.5% |
| Gelir büyüme oranı | 16.4% |
| Özkaynak getirisi | 20.8% |
| Net Marj | 18.4% |
| Sonraki Kazanç Güncellemesi | 05 Nov 2024 |
Yakın geçmiş performans güncellemeleri
Recent updates
Here's Why Mankind Pharma (NSE:MANKIND) Can Manage Its Debt Responsibly
Aug 26
Risks To Shareholder Returns Are Elevated At These Prices For Mankind Pharma Limited (NSE:MANKIND)
Jul 12Here's Why Mankind Pharma (NSE:MANKIND) Has Caught The Eye Of Investors
May 08Mankind Pharma Limited's (NSE:MANKIND) Business Is Trailing The Market But Its Shares Aren't
Apr 08Mankind Pharma Limited Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Feb 04Gelir ve Gider Dağılımı
Mankind Pharma nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.
Kazanç ve Gelir Geçmişi
| Tarih | Gelir | Kazançlar | G+A Giderleri | Ar-Ge Giderleri |
|---|---|---|---|---|
| 30 Jun 24 | 106,496 | 19,625 | 29,827 | 0 |
| 31 Mar 24 | 103,348 | 19,129 | 29,018 | 0 |
| 31 Dec 23 | 99,463 | 17,271 | 25,832 | 0 |
| 30 Sep 23 | 94,303 | 15,575 | 24,863 | 0 |
| 30 Jun 23 | 91,481 | 14,762 | 20,174 | 0 |
| 31 Mar 23 | 87,494 | 12,819 | 23,126 | 0 |
| 31 Dec 22 | 84,225 | 11,865 | 22,717 | 0 |
| 31 Mar 22 | 77,816 | 14,335 | 20,934 | 0 |
| 31 Mar 21 | 62,144 | 12,654 | 18,195 | 0 |
| 31 Mar 20 | 58,719 | 10,304 | 16,082 | 0 |
| 31 Mar 19 | 49,800 | 5,785 | 14,709 | 0 |
Kaliteli Kazançlar: MANKIND has high quality earnings.
Büyüyen Kar Marjı: MANKIND's current net profit margins (18.4%) are higher than last year (16.1%).
Serbest Nakit Akışı ve Kazanç Analizi
Geçmiş Kazanç Büyüme Analizi
Kazanç Eğilimi: MANKIND's earnings have grown by 12.6% per year over the past 5 years.
Büyüme Hızlandırma: MANKIND's earnings growth over the past year (32.9%) exceeds its 5-year average (12.6% per year).
Kazançlar vs. Sektör: MANKIND earnings growth over the past year (32.9%) exceeded the Pharmaceuticals industry 19.1%.
Özkaynak Getirisi
Yüksek ROE: MANKIND's Return on Equity (20.8%) is considered high.